Brief: Biophytis Begins Regulatory Process For Early Access Authorization For Treatment Of COVID-19

Biophytis SA

27/02/2023 07:39

Feb 27 (Reuters) - Biophytis Sa  ALBPS.PA :
    * BIOPHYTIS INITIATES THE REGULATORY PROCESS FOR AN EARLY
ACCESS
AUTHORIZATION IN FRANCE FROM THE FRENCH NATIONAL AUTHORITY FOR
HEALTH (HAS) FOR THE TREATMENT WITH SARCONEOS (BIO101) OF SEVERE
FORMS OF COVID-19
    * BIOPHYTIS STARTS REGULATORY PROCESS FOR EARLY ACCESS
AUTHORIZATION IN FRANCE FOR SEVERE COVID-19 TREATMENT SARCONEOS
    * BIOPHYTIS TO PRESENT EARLY ACCESS APPLICATION IN FRANCE AT
A
PRE-FILING MEETING IN MARCH 2023 WITH NATIONAL AUTHORITY FOR
medrHEALTH
    * BIOPHYTIS IS PURSUING PARALLEL PREPARATION OF CONDITIONAL
MARKETING AUTHORIZATION APPLICATION DUE TO HEALTH EMERGENCY IN
EUROPE AND USA

Source text for Eikon:  ID:nEQ6S0X4Fa 
Further company coverage:  ALBPS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;;))